Peptidylarginine deiminase type I, type II, type III and type IV are expressed in rat epidermis

被引:26
|
作者
Ishigami, A
Asaga, H
Ohsawa, T
Akiyama, K
Maruyama, N
机构
[1] Tokyo Metropolitan Inst Gerontol, Dept Bioact Regulat, Itabashi Ku, Tokyo 1730015, Japan
[2] Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo 1730015, Japan
来源
BIOMEDICAL RESEARCH-TOKYO | 2001年 / 22卷 / 01期
关键词
D O I
10.2220/biomedres.22.63
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Peptidylarginine deiminases (PADs) are post-translational modification enzymes to convert protein arginine to citrulline residues in a calcium ion-dependent manner. Here, we investigated the tissue specific expression of PAD type T, II, III and IV by using a reverse transcription-polymerase chain reaction (RT-PCR) method. The type I mRNA was detected only in the epidermis and stomach, and type III mRNA was detected only in the epidermis and ovary. On the other hand, the type II and type IV mRNAs were found in a variety of tissues such as the epidermis, lung, spleen, stomach, kidney, ovary and uterus. The epidermis is the only tissue in which all four PAD mRNAs were detected. The present study suggests strongly that PADs play functionally important roles during the terminal differentiation of epidermal keratinocytes.
引用
收藏
页码:63 / 65
页数:3
相关论文
共 50 条
  • [21] Immunocytochemical localization of peptidylarginine deiminase type III, trichohyalin and deiminated trichohyalin in infant rat dorsal skin hair follicle
    Ohsawa, T
    Ishigami, A
    Akiyama, K
    Asaga, H
    BIOMEDICAL RESEARCH-TOKYO, 2001, 22 (02): : 91 - 97
  • [22] The developmental role of type III and type IV cells in the rat submandibular gland
    Nagato, T
    Nagaki, M
    Kodama, J
    Toh, H
    Tandler, B
    EUROPEAN JOURNAL OF MORPHOLOGY, 1998, 36 : 123 - 127
  • [23] TYPE-I WITHOUT TYPE-III AND TYPE-IV HYPERSENSITIVITY REACTION TO NICKEL
    MITCHELL, JC
    CONTACT DERMATITIS, 1981, 7 (05) : 270 - 270
  • [24] IMMUNOCYTOCHEMICAL DEMONSTRATION OF SKELETAL-MUSCLE TYPE PEPTIDYLARGININE DEIMINASE IN VARIOUS RAT-TISSUES
    AKIYAMA, K
    INOUE, K
    SENSHU, T
    CELL BIOLOGY INTERNATIONAL REPORTS, 1990, 14 (03) : 267 - 273
  • [25] Negative regulation of the peptidylarginine deiminase type IV promoter by NF-κB in human myeloid cells
    Abbas, Ali K.
    Le, Kevin
    Pimmett, Virginia L.
    Bell, David A.
    Cairns, Ewa
    DeKoter, Rodney P.
    GENE, 2014, 533 (01) : 123 - 131
  • [26] A continuous spectrophotometric assay method for peptidylarginine deiminase type 4 activity
    Liao, YF
    Hsieh, HC
    Liu, GY
    Hung, HC
    ANALYTICAL BIOCHEMISTRY, 2005, 347 (02) : 176 - 181
  • [27] Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase type I
    Unno, Masaki
    Kinjo, Saya
    Kizawa, Kenji
    Takahara, Hidenari
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2013, 69 : 1357 - 1359
  • [28] Human peptidylarginine deiminase type I: Full-length cDNA cloning and expression analysis
    Guerrin, M
    Ishigami, A
    Sebbag, M
    Senshu, T
    Serre, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 543 - 543
  • [29] Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin
    Ishigami, A
    Ohsawa, T
    Asaga, H
    Akiyama, K
    Kuramoto, M
    Maruyama, N
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 407 (01) : 25 - 31
  • [30] Type I, Type II, and Occasionally Type III How Can We Go Wrong?
    Maltenfort, Mitchell
    JOURNAL OF SPINAL DISORDERS & TECHNIQUES, 2015, 28 (05): : 189 - 189